About ZenBio
Founded in 1995, ZenBio, a BIOIVT company, develops human cell-based research products and contract research services for discovery science applications. The company specialises in primary cells, tissue-derived products, cell culture systems and custom assay development. Its technologies enable researchers to evaluate biological responses in physiologically relevant in vitro models. ZenBio supports preclinical screening, drug discovery, tissue procurement and molecular characterisation workflows. Research areas include metabolic disease, obesity, diabetes, wound healing, inflammation, cosmetics and personal care science. The company operates from Research Triangle Park, North Carolina, and collaborates with academic, biotechnology and pharmaceutical research organisations.
ZenBio’s portfolio includes human primary cells, cell and tissue-derived products, exosomes, media, sera, research kits and laboratory consumables. Its ZenComplete™ and ZenSkin™ platforms provide integrated cell-based research solutions for biomedical and cosmetic applications. The company also offers contract assay services, cell-based screening programmes, cell characterisation and consulting support. Assays using cultured human adipocyte systems support studies of metabolic function and therapeutic candidates. Additional products include human airway, bladder and immune cell models, together with extracellular vesicle and exosome research tools.
Europa Biosite’s subsidiaries distribute for ZenBio in Canada, Ireland, Switzerland, United Kingdom and the United States of America.